Rapid decline of noninvasive fibrosis index values in patients with hepatitis C receiving treatment with direct-acting antiviral agents

BACKGROUND: Studies on temporal changes in noninvasive fibrosis indices and liver stiffness measurement (LSM) in patients with chronic hepatitis C (CHC) treated with direct-acting antiviral agents (DAAs) are limited. METHODS: We retrospectively enrolled consecutive patients with CHC who had received...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:BMC Gastroenterol
Egile Nagusiak: Hsu, Wei-Fan, Lai, Hsueh-Chou, Su, Wen-Pang, Lin, Chia-Hsin, Chuang, Po-Heng, Chen, Sheng-Hung, Chen, Hung-Yao, Wang, Hung-Wei, Huang, Guan-Tarn, Peng, Cheng-Yuan
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2019
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6486982/
https://ncbi.nlm.nih.gov/pubmed/31029101
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12876-019-0973-5
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak